EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early‐ and late‐onset Alzheimer's disease

Neus Falgàs iD, Marta Peña-González, Andrea Val-Guardiola, Agnès Pérez-Millan, Núria Guillén, Jordi Sarto, Diana Esteller, Beatriz Bosch, Guadalupe Fernández-Villullas, Adrià Tort-Merino, Gerard Mayà, Josep Maria Augé und 8 weitere

Alzheimer's & Dementia · 2024-09 · 20 (9) · 6351-6364

DOI: 10.1002/alz.14131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 25.07.2024. Verfasst von Neus Falgàs und 19 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic de Barcelona, Fundació de Recerca Clínic Barcelona-IDIBAPS, Universitat de Ba…. Hauptthemen laut MEDLINE: Locus Coeruleus, Alzheimer Disease, Norepinephrine, Biomarkers. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Union, ISCIII, NIA NIH HHS, Instituto de Salud Carlos III (ISCIII).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Early‐onset Alzheimer's disease (EOAD) shows a higher burden of neuropsychiatric symptoms than late‐onset Alzheimer's disease (LOAD). We aim to determine the differences in the severity of neuropsychiatric symptoms and locus coeruleus (LC) integrity between EOAD and LOAD accounting for disease stage. METHODS One hundred four subjects with AD diagnosis and 32 healthy controls were included. Participants underwent magnetic resonance imaging (MRI) to measure LC integrity, measures of noradrenaline levels in cerebrospinal fluid (CSF) and Neuropsychiatric Inventory (NPI). We analyzed LC‐noradrenaline measurements and clinical and Alzheimer's disease (AD) biomarker associations. RESULTS EOAD showed higher NPI scores, lower LC integrity, and similar levels of CSF noradrenaline compared to LOAD. Notably, EOAD exhibited lower LC integrity independently of disease stage. LC integrity negatively correlated with neuropsychiatric symptoms. Noradrenaline levels were increased in AD correlating with AD biomarkers. DISCUSSION Decreased LC integrity negatively contributes to neuropsychiatric symptoms. The higher LC degeneration in EOAD compared to LOAD could explain the more severe neuropsychiatric symptoms in EOAD. Highlights LC degeneration is greater in early‐onset AD (EOAD) compared to late‐onset AD. Tau‐derived LC degeneration drives a higher severity of neuropsychiatric symptoms. EOAD harbors a more profound selective vulnerability of the LC system. LC degeneration is associated with an increase of cerebrospinal fluid noradrenaline levels in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Locus CoeruleusAlzheimer DiseaseNorepinephrineBiomarkersMagnetic Resonance ImagingHumansMaleFemaleAgedMiddle AgedNeuropsychological TestsCohort StudiesAge of Onset

Stichwörter der Autor:innen

Alzheimer's diseaseearly‐onset Alzheimer's diseaselocus coeruleusneuromodulatory subcortical systemsneuropsychiatric symptomsselective vulnerability

Substanzen

NorepinephrineBiomarkers

Autor:innen und Institutionen

  • Alzheimer's Disease and Other Cognitive Disorders Unit, Hospital Clínic de Barcelona, Fundació de Recerca Clínic Barcelona-IDIBAPS, Universitat de Barcelona, Barcelona, Catalonia, Spain.
  • Global Brain Health Institute, University of California, San Francisco, California, USA.
  • Magnetic Resonance Imaging Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.
  • Neurology Service, Hospital Clínic de Barcelona, IDIBAPS, CIBERNED, Universitat de Barcelona, Barcelona, Spain.
  • Biochemistry and Molecular Genetics Department-CDB, Hospital Clinic, IDIBAPS, CIBERehd, Barcelona, Spain.
  • Department of Neurology, Memory & Aging Center, Weill Institute for Neurosciences, University of California, San Francisco, California, USA.

ORCID-Profile: Neus Falgàs

Förderung

  • European Union, ISCIII
  • NIA NIH HHS
  • Instituto de Salud Carlos III (ISCIII)
  • Alzheimer's Association
  • Global Brain Health Institute, Alzheimer's Association, Alzheimer's Society UK
  • Fundación BBVA

Zitieren

APA

Falgàs, N., Peña-González, M., Val-Guardiola, A., Pérez-Millan, A., Guillén, N., Sarto, J., Esteller, D., Bosch, B., Fernández-Villullas, G., Tort-Merino, A., Mayà, G., Augé, J. M., Iranzo, A., Balasa, M., Lladó, A., Morales-Ruiz, M., Bargalló, N., Muñoz-Moreno, E., Grinberg, L. T., & Sánchez-Valle, R. (2024). Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early‐ and late‐onset Alzheimer's disease. Alzheimer's & Dementia, 20(9), 6351-6364. https://doi.org/10.1002/alz.14131

Vancouver

Falgàs N, Peña-González M, Val-Guardiola A, Pérez-Millan A, Guillén N, Sarto J, et al. Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early‐ and late‐onset Alzheimer's disease. Alzheimer's & Dementia. 2024;20(9):6351-6364. doi:10.1002/alz.14131

BibTeX
@article{Falgs2024,
  author = {Falgàs, Neus and Peña-González, Marta and Val-Guardiola, Andrea and Pérez-Millan, Agnès and Guillén, Núria and Sarto, Jordi and Esteller, Diana and Bosch, Beatriz and Fernández-Villullas, Guadalupe and Tort-Merino, Adrià and Mayà, Gerard and Augé, Josep Maria and Iranzo, Alex and Balasa, Mircea and Lladó, Albert and Morales-Ruiz, Manuel and Bargalló, Núria and Muñoz-Moreno, Emma and Grinberg, Lea T and Sánchez-Valle, Raquel},
  title = {Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early‐ and late‐onset Alzheimer's disease},
  journal = {Alzheimer's & Dementia},
  year = {2024},
  volume = {20},
  number = {9},
  pages = {6351--6364},
  doi = {10.1002/alz.14131}
}
Kostenlos starten →